Nicotine Containing Dental Floss
Keep away cavities and cancer at the same time.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120083468 | METHOD FOR PREPARING A MEDICAL SOLUTION FOR THE MANUFACTURE OF A MEDICAMENT FOR PERITONEAL DIALYSIS A method of preparing a medical solution includes the steps of a) providing a solution having one or more acetylated or deacetylated amino sugar/sugars in at least one compartment of a container at a pH of from 2.5 to 5.0, and b) terminal sterilization of the compartmen... | 04/05/2012 |
| 20120040012 | THERAPEUTIC STEM CELL NUTRIENT COMPOSITION AND USES THEREOF The present invention relates to a composition and uses thereof for treatment of damaged tissue comprising at least one essential amino acid in L form and at least one essential lipid; wherein the composition is administered to a mammal suffering from severe tissue dama... | 02/16/2012 |
| 20120040929 | FOOD COMPOSITION COMPRISING GLUCOSAMINE The present invention relates to an orally ingestible food or pet food composition or cosmetic composition containing glucosamine generated from plant materials through a drying process for the maintenance of joint health or prevention, alleviation and/or treatment of o... | 02/16/2012 |
| 20120027699 | SKIN CARE COMPOSITIONS COMPRISING SUBSTITUTED MONOAMINES Skin care compositions comprising certain substituted monoamines, which are particularly beneficial for skin lightening and achieving evenness of color, especially for face and underarm skin.... | 02/02/2012 |
| 20120027700 | SKIN CARE COMPOSITIONS COMPRISING SUBSTITUTED DIAMINES Skin care compositions comprising certain substituted diamines, which are particularly beneficial for skin lightening and achieving evenness of color, especially for face and underarm skin.... | 02/02/2012 |
| 20120015011 | COSMETIC COMPOSITION COMPRISING DOUBLE-SHELL NANO-STRUCTURE Disclosed is a cosmetic composition having a double-shell type nano-structure. More particularly, the nano-structure of the cosmetic composition includes: a water-soluble bioactive ingredient core; a core shell containing poly(ethyleneglycol)-poly(caprolactone)-poly(eth... | 01/19/2012 |
| 20120003320 | Particles which are surface coated with hyaluronan or one of the derivatives thereof and the use of same as biological vectors for active substances Particles comprising a core based on at least one biodegradable organosoluble polymer. At least a part of the surface of the particles is coated with at least one hyaluronan or a derivative thereof, the hyaluronan being a water-soluble, amphiphilic hyaluronan of which t... | 01/05/2012 |
| 20110318321 | CONTROLLED RELEASE PHARMACEUTICAL OR FOOD FORMULATION AND PROCESS FOR ITS PREPARATION The present invention relates to a controlled release pharmaceutical or food formulation comprising at least one active pharmaceutical or food ingredient dispersed in a mixture of a glycogen with a polysaccharide, and the process for its preparation. The invention also ... | 12/29/2011 |
| 20110319358 | GLUCOSAMINE AND METHOD OF MAKING GLUCOSAMINE FROM MICROBIAL BIOMASS Glucosamine suitable for human or animal consumption is disclosed. The glucosamine is derived from fungal biomass containing chitin. Various methods of producing glucosamine by acid hydrolysis of fermented fungal biomass are also disclosed.... | 12/29/2011 |
| 20110274746 | Therapeutic Liposomes and Methods For Producing and Using the Same The present invention provides therapeutic liposomes and methods for producing and using the same. In particular, therapeutic liposomes of the invention comprise phospholipids comprising C16-C22 fatty acid ester moieties. In some embodiments, these... | 11/10/2011 |
| 20110256247 | TOPICAL COMPOSITIONS CONTAINING NITRO FATTY ACIDS Activated fatty acids, topical compositions including activated fatty acids and methods for using activated fatty acids to treat a variety of diseases.... | 10/20/2011 |
| 20110245202 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RHINITIS The present invention relates to a pharmaceutical composition suitable for the prophylactic and/or curative topical treatment of rhinitis, said composition containing in combination and in each case in pharmaceutically efficacious amounts: ... | 10/06/2011 |
| 20110237544 | Novel Pharmaceutical Agents Containing Carbohydrate Moieties And Methods Of Their Preparation And Use Hydrophilic N-linked pharmaceutical compositions, methods of their preparation and use in neuraxial drug delivery comprising a glycosyl CNS acting prodrug compound covalently N-linked with a saccharide through an amide or an amine bond and a formulary consisting of an a... | 09/29/2011 |
| 20110236461 | METHODS FOR STIMULATING CHONDROGENESIS UTILIZING A POTASSIUM CHANNEL INHIBITOR The invention is directed to a method for stimulating chondrogenesis comprising administering to a subject in need thereof a composition comprising a therapeutically effective amount of a potassium channel inhibitor.... | 09/29/2011 |
| 20110224599 | COMBINATION OF AN OXIDANT AND A PHOTOACTIVATOR FOR THE HEALING OF WOUNDS There is provided wound healing composition which comprises at least one oxidant, at least one photoactivator capable of actuating the oxidant and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin in association with a pharmaceutically a... | 09/15/2011 |
| 20110218482 | OXIDATITIVE PHOTOACTIVATED SKIN REJEUVENATION COMPOSITION COMPRISING HYALURONIC ACID, GLUCOSAMINE, OR ALLANTOIN There is provided a skin rejuvenation composition which comprises at least one oxidant, at least one photoactivator capable of activating the oxidant, and at least one healing factor chosen from hyaluronic acid, glucosamine and allantoin, in association with a pharmaceu... | 09/08/2011 |
| 20110212917 | AGENT FOR AMELIORATING BRAIN HYPOFUNCTION Provided are effective and highly safe agents, medicaments and the like for ameliorating various disorders caused by brain hypofunction. Also provided is a preventing or ameliorating agent for brain hypofunction containing N-acetyl-D-mannosamine, a pharmaceutical compos... | 09/01/2011 |
| 20110206661 | TRIMETHOXYPHENYL INHIBITORS OF TYROSINE KINASE The present invention relates to new trimethoxyphenyl inhibitors of tyrosine kinase, pharmaceutical compositions thereof, and methods of use thereof. ... | 08/25/2011 |
| 20110206734 | HYBRID SCFA-HYDROXYL-DERIVATIZED MONOSACCHARIDES, METHODS OF SYNTHESIS, AND METHODS OF TREATING DISORDERS Described herein are fatty acid carbohydrate-hydroxyl-hybrid compounds and derivatives thereof, and methods of treating or preventing disease and disease symptoms using the compounds and compositions thereof.... | 08/25/2011 |
| 20110195066 | QUINOLINE INHIBITORS OF TYROSINE KINASE The present invention relates to new quinoline inhibitors of tyrosine kinases, pharmaceutical compositions thereof, and methods of use thereof. ... | 08/11/2011 |
| 20110183018 | Cholesterol Sulfate And Amino Sugar Compositions For Enhancement Of Stratum Corneum Function The present invention provides compositions containing a mixture of cholesterol sulfate and an exfoliant. The exfoliant can be N-acetyl-D-glucosamine, N-acetylgalactosamine, or a combination thereof. The combination of cholesterol sulfate with the exfoliant surprisingly... | 07/28/2011 |
| 20110183892 | METHODS FOR THE TREATMENT OF VIRAL CONDITIONS The invention is directed to a method of stimulating PRF in a viral cell by administering an aminoglycoside antibiotic to said cell. In another embodiment, the invention is directed to a method of inhibiting viral replication by administering an aminoglycoside antibioti... | 07/28/2011 |
| 20110182869 | TREATMENT OF GUT MOTILITY DISORDERS This invention relates to products comprising antibiotics or probiotics and the use thereof for the treatment of gut motility disorders such as irritable bowel syndrome (IBS).... | 07/28/2011 |
| 20110171289 | COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS The present invention relates to a pharmaceutical combination for the treatment of diseases which involves cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis. The invention also relates to a method for the treatment of said diseases, comprising... | 07/14/2011 |
| 20110171319 | NUTRITIONAL COMPOSITION MADE USING ISOLATED ORGANIC MATTER Nutritional compositions, formulations, and intermediates are provided which may be utilized to formulate various sweeteners and other products. The formulations described herein are made from constituents found in soils or fossilized soils.... | 07/14/2011 |
| 20110171187 | DIETARY SUPPLEMENTS FOR PROMOTION OF GROWTH, REPAIR, AND MAINTENANCE OF BONE AND JOINTS The present invention provides a dietary supplement that promote the growth, repair, and maintenance of mammalian bone and joint connective tissue. In particular, the dietary supplement comprises a combination of at least one metal chelate and at least one chondroprotec... | 07/14/2011 |
| 20110150880 | METHODS AND COMPOSITIONS RELATING TO SYNTHETIC BETA-1,6 GLUCOSAMINE OLIGOSACCHARIDES The invention relates to the compositions of synthetic oligo-β-(1→6)-2-amino-2-deoxy-D-glucopyranosides conjugated to carriers, and methods for making and use same.... | 06/23/2011 |
| 20110123516 | NITROGENATED DERIVATIVES OF PANCRATISTATIN The present invention concerns nitrogenated derivatives of narciclasine and pancratistatin of the following general formula (I) as well their pharmaceutically acceptable salts. The present invention also concerns the use of these compounds in cancer therapy as well as a... | 05/26/2011 |
| 20110124579 | SIALIC ACID TO SUPPORT SALIVATION The present invention generally relates to the field of disorders related to an impaired salivation and compositions that can be used to treat or prevent such disorders. One embodiment of the present invention relates to a composition comprising sialic acid to treat and... | 05/26/2011 |
| 20110110914 | METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS Methods and formulations for treating oncological disorders in humans using epimetabolic shifters, multidimensional intracellular molecules or environmental influencers are described.... | 05/12/2011 |
| 20110071111 | CICLETANINE IN COMBINATION WITH ORAL ANTIDIABETIC AND/OR BLOOD LIPID-LOWERING AGENTS AS A COMBINATION THERAPY FOR DIABETES AND METABOLIC SYNDROME Preferred embodiments of the present invention are related to novel therapeutic drug combinations and methods for treating and/or preventing complications in patients with diabetes and/or metabolic syndrome. More particularly, aspects of the present invention are relate... | 03/24/2011 |
| 20110053890 | SYNTHETIC ANALOGS OF BACTERIAL QUORUM SENSORS Bacterial quorum-sensing molecule analogs having the following structures: and methods of reducing bacterial pathogenicity, comprising providing a biological system comprising pathogenic bacteria which produc... | 03/03/2011 |
| 20110053889 | Prenatal and postnatal screening and treatment of critical monosaccharide deficiencies for neurologic and immunologic function A method for determining the effect of critical glyconutrient dietary supplements in premature and term infants on growth, health, and brain function during early childhood development is described. The method comprises determining a critical target nutrient profile in ... | 03/03/2011 |
| 20110046087 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF The invention relates to the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia using a SGLT-2 inhibitor. In addition the present invention relates to methods f... | 02/24/2011 |
| 20110034413 | NOVEL QUERCETIN DERIVATIVES AS ANTI-CANCER AGENTS The present invention provides novel Quercetin derivatives of formula (I) and pharmaceutically acceptable salts, hydrates, and solvates thereof, wherein R1 is hydrogen, benzyl or substituted benzyl... | 02/10/2011 |
| 20110027357 | Compositions and methods for timed release of water-soluble nutritional supplements A timed or controlled release composition is provided where a plurality of active pellets is layered with a controlled release layer whereby the single functional component of the controlled release layer is shellac and/or a shellac based material.... | 02/03/2011 |
| 20110020312 | METHODS FOR TREATMENT OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS Methods and formulations for treating metabolic disorders in humans using epimetabolic shifters, multidimensional intracellular molecules or environmental influencers are described.... | 01/27/2011 |
| 20110003016 | HAIR CARE COMPOSITION A hair treatment composition comprising a trichogenic material and an anti-dandruff agent.... | 01/06/2011 |
| 20100330198 | AMINOSUGAR, GLYCOSAMINOGLYCAN, AND S-ADENOSYLMETHIONINE COMPOSITION FOR THE TREATMENT AND REPAIR OF CONNECTIVE TISSUE A composition for the protection, treatment and repair and for reducing the inflammation of connective tissue in mammals and a method for the treatment of connective tissue in mammals by the administration of the composition. The composition includes S-Adenosylmethionin... | 12/30/2010 |
| 20100322983 | Personal-Care Composition A personal-care composition in the form of an oil-in-water emulsion is disclosed that provides improved skin feel and effective wrinkle-filling. The personal-care composition comprises a silicone elastomer; a silicone fluid; a combination of particulate materials; a pol... | 12/23/2010 |